Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 24, Issue 1, 2007, Pages 13-23

  Ricci, Alberto ^a   Graziano, Paolo ^b   Bronzetti, Elena ^a   Saltini, Cesare ^c   Sciacchitano, Salvatore ^a   Cherubini, Emanuela ^f   Renzoni, Elisabetta ^d   Du Bois, Roland M ^d   Grutters, Jan C ^e   Mariotta, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f Ospedale Sant'Andrea ^*

Author keywords

Fibroblasts; Interstitial lung diseases; Neurotrophins

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN RECEPTOR; PROTEIN;

ADULT; AGED; ARTICLE; BRONCHIOLITIS ASSOCIATED INTERSTITIAL LUNG DISEASE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEUROTROPHIN 3; PULMONARY FIBROSIS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 36549038139     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. American Thoracic Society/European Respiratory Society: International multidisciplinary consensus classification of idiopathic interstitial pneumonias: general principles and recommendations. Am J Respir Crit Care Med 2002; 165: 277-304.
2. Kuwano K, Hagimoto N, Maeyama T, et al: Mitochondria mediated apoptosis of lung epithelial cells in idiopatic interstitial pneumonias. Lab Invest 2002; 82: 1695-706.
3. Renzoni EA, Walsh DA, Salmon M, et al: Interstitial vascularity in fibrosing alveolitis. Am. J Respir Crit Care Med 2003; 167: 438-443.
4. Zhao HW, Lu CJ, Yu RJ, Hou XM: An increase in hyaluronan by lung fibroblasts: a biomarker for intensity and activity of interstitial pulmonary fibrosis? Respirology 1999; 4: 131-8.
5. Zicsche R, Hofbauer E, Wittmann K, Petkov V, Block LH: A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341: 1264-9.
6. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T: Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 382-5.
7. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J: Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100: 768-76.
8. Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S, Horie T: TGF-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a JNK-dependent pathway. Am J Respir Crit Care Med 2001; 163: 152-7.
9. Raghu G, Chen YY, Rusch V, Rabinovitch PS: Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am Rev Respir Dis 1988; 138: 703-8.
10. Ramos C, Montann M, Garcia-Alvarez J, et al: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol 2001; 24: 591-8.
11. Vancheri C, Sortino MA, Tomaselli V, et al: Different expression of TNF-alpha receptors and prostaglandin E(2) production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 2000; 22: 628-34.
12. Selman M, Thannickal VJ, Pardo A, Zisman DA, Martinez FJ, Lynch JP 3rd: Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs 2004; 64: 405-30.
13. Selman M, Pardo A: Idiopathic pulmonary fibrosis: an epithelial/ fibroblastic cross-talk disorder. Respir Res 2002; 3: 3-12.
14. Winkler MK, Fowlkes JL: Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol 2002; 283: 1-11.
15. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS: Neurotrophic factors: from molecule to man. Trends Neurosci 1994; 17: 182-90.
16. Bonini S, Lambiase A, Bonini S, Levi-Schaffer F, Aloe L: Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int Arch Allergy Immunol 1999; 118: 159-62.
17. Ebadi M, Bashir RM, Heidrick ML, et al: Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 1997; 30: 347-4.
18. Cartwright M, Mikheev AM, Heinrich G: Expression of neurotrophin genes in human fibroblasts: differential regulation of the brain-derived neurotrophic factor gene. Int J Dev Neurosci 1994; 12: 685-93.
19. Micera A, Vigneti E, Pickholtz D, et al: Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001; 98: 6162-7.
20. Ricci A, Felici L, Mariotta S, et al: Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol 2004; 30: 12-9.
21. Olgart C, Frossard N: Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. Eur Respir J 2001; 18: 115-21.
22. Matucci-Cerinic M, Giacomelli R, Pignone A, et al: Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma). Ann Rheum Dis 2001; 60: 487-94.
23. Kasemkijwattana C, Menetrey J, Bosch P, et al: Use of growth factors to improve muscle healing after strain injury. Clin Orthop 200; 370: 272-85.
24. Hattori A, Hayashi K, Kohno M: Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor. FEBS Lett 1996; 379: 157-60.
25. Hasan W, Zhang R, Liu M, Warn JD, Smith PG: Coordinate expression of NGF and alpha-smooth muscle actin mRNA and protein in cutaneous wound tissue of developing and adult rats. Cell Tissue Res 2000; 300: 97-109.
26. Kasemkijwattana C, Menetrey J, Somogyl G, et al: Development of approaches to improve the healing following muscle contusion. Cell Transplant 1998; 7: 585-98.
27. Kawamoto K, Matsuda H: Nerve growth factor and wound healing. Prog Brain Res 2004; 146: 369-84.
28. Katzenstein AL, Myers JL: Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-15.
29. Zhang K, Rekhter MD, Gordon D, Phan SH: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol 1994; 145: 114-25.
30. Fukuda Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N: Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 1998; 78: 687-98.
31. Khan KM, Falcone DJ, Kraemer R: Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 2002; 277: 2353-9.
32. Machida CM, Rodland KD, Matrisian L, Magun BE, Ciment G: NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells. Neuron 1989; 2: 1587-96.
33. Ernfors P, Lee KF, Jaenisch R: Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 1994; 368: 147-50.
34. Jones KR, Farinas I, Backus C, Reichardt LF: Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 1994; 76: 989-99.
35. Braun A, Lommatzsch M, Neuhaus-Steinmetz U, et al: Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. Br J Pharmacol 2004; 141: 431-40.
36. Takeo C, Nakamura S, Tanaka T, et al: Rat cerebral endothelial cells express trk C and are regulated by neurotrophin-3. Biochem Biophys Res Commun 2003; 305: 400-6.
37. Jin L, Hu X, Feng L: NT3 inhibits FGF2-induced neural progenitor cell proliferation via the PI3K/GSK3 pathway. J Neurochem 2005; 93: 1251-61.
38. Lukaszewicz A, Savatier P, Cortay V, Kennedy H, Dehay C: Contrasting effects of basic fibroblast growth factor and neurotrophin 3 on cell cycle kinetics of mouse cortical stem cells. J Neurosci 2002; 22: 6610-22.
39. Rabizadeh S, Bredesen DE: Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). Cytokine Growth Factor Rev 2003; 14: 225-39.
40. Brodie C: Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes. FEBS Lett 1996; 394: 117-20.
41. Ma D, Wolvers D, Stanisz AM, Bienenstock J: Interleukin-10 and nerve growth factor have reciprocal upregulatory effects on intestinal epithelial cells. Am J Physiol Regul Integr Camp Physiol 2003; 284: R1323-1329.
42. Barouch R, Kazimirsky G, Appel E, Brodie C: Nerve growth factor regulates TNF-alpha production in mouse macrophages via MAP kinase activation. J Leukoc Biol 2001; 69: 1019-26.